Join the Lupron group to help and get support from people like you.
Lupron News
Enzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer
WEDNESDAY, Oct. 18, 2023 – For patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus leuprolide is best for metastasis-free survival, according to a study published...
Ask a question
To post your own question to this support group, sign in or create an account.